Cancer stem cells

Revista de Investigacion Clinica

Volumn 63, Issue 2, 2011, Pages 179-186

  Schwarz Cruz y Celis, Ángela ^a   Meléndez Zajgla, Jorge ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cancer; Cancer stem cells; Differentiation; Self renewal; Therapeutic resistance

Indexed keywords

BETA1 INTEGRIN; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CD24 ANTIGEN; CD38 ANTIGEN; CELL MARKER; CYCLOPAMINE; FUMITREMORGIN C; GAMMA SECRETASE INHIBITOR; HERMES ANTIGEN; IMATINIB; LAPATINIB; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN;

CANCER IMMUNOTHERAPY; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL RENEWAL; CHRONIC MYELOID LEUKEMIA; DRUG MECHANISM; HUMAN; MOLECULARLY TARGETED THERAPY; NONHUMAN; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; CELL DIVISION; CELL LINEAGE; CELL SEPARATION; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; HUMANS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; TUMOR MARKERS, BIOLOGICAL;

EID: 79959941915     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell 2000; 100(1): 57-70. (Pubitemid 30046295)
2. Marotta LL, Polyak K. Cancer stem cells: a model in the making. Curr Opin Genet Dev 2009; 19(1): 44-50.
3. Costa FF, Le Blanc K, Brodin B. Concise Review: Cancer/Testis Antigens, Stem Cells, and Cancer. Stem Cells 2007; 25(3): 707-11.
4. Dick JE. Acute Myeloid Leukemia Stem Cells. Ann NY Acad Sci 2005; 1044: 1-5.
5. Dontu G. Breast cancer stem cell markers-the rocky road to clinical applications. Breast Cancer Res 2008; 10(5): 110.
6. Cheshier SH, Kalani MY, Lim M, et al. A Neurosurgeon's Guide to Stem Cells, Cancer Stem Cells, and Brain Tumor Stem Cells. Neurosurg 2009; 65(2): 237-49.
7. Dick JE. Breast cancer stem cells revealed. Proc Natl Acad Sci USA 2003; 100(7): 3547-9. (Pubitemid 36418067)
8. Chumsri S, Phatak P, Edelman MJ, et al. Cancer Stem Cells and Individualized Therapy. Cancer Genomics Proteomics 2007; 4(3): 165-74. (Pubitemid 46813092)
9. Ponti D, Costa A, Zaffaroni N, et al. Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties. Cancer Res 2005; 65(13): 5506-11. (Pubitemid 40911148)
10. Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104(24): 10158-63. (Pubitemid 47175279)
11. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432(7015): 396-401. (Pubitemid 39551674)
12. Charafe-Jauffret E, Ginestier C, Birnbaum D. Breast cancer stem cells: tools and models to rely on. BMC Cancer 2009; 9: 202.
13. Liu R, Wang X, Chen GY, et al. The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells. N Engl J Med 2007; 356(3): 217-26. (Pubitemid 46143225)
14. Acevedo PA, Cortés MM. Células madre: generalidades, eventos biológicos y moleculares. Iatreia 2008; 21(3): 292-306.
15. Yang ZF, Ho DW, Ng MN, et al. Significance of CD90+ Cancer Stem Cells in Human Liver. Cancer Cell 2008; 13(2): 153-66. (Pubitemid 351163165)
16. Dean M, Fojo T, Bates S. Tumor stem cells and drug resistance. Nat Rev Cancer 2005; 5(4): 275-84. (Pubitemid 40488633)
17. Ponnusamy MP, Batra SK. Ovarian Cancer: Emerging concept on cancer stem cells. J Ovarian Res 2008; 1(1): 4.
18. Ashkenazi R, Gentry SN, Jackson TL. Pathways to tumorigenesis-modeling mutation acquisition in stem cells and their progeny. Neoplasia 2008; 10(11): 1170-82.
19. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006; 441(7097): 1068-74. (Pubitemid 43990718)
20. Wang QZ, Lu YH, Jiang N, et al. The asymmetric division and tumorigenesis of stem cells. Chin J Cancer 2010; 29(3): 248-53.
21. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001; 414(6859): 105-11.
22. Jordan CT, Guzman ML, Noble M. Cancer Stem Cells. N Engl J Med 2006; 355(12): 1253-61.
23. Mayani H. Las Células Troncales Somáticas: Biología y Relevancia Clínica. En: Brena I (ed.). Células Troncales: Aspectos científicos-filosóficos y jurídicos. México D. F.: Universidad Nacional Autónoma de México; 2005, p. 1-24.
24. Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science 2009; 324(5935): 1673-7.
25. Gao JX. Cancer stem cells: the lesson from pre-cancerous stem cells. J Cell Mol Med 2008; 12(1): 67-96.
26. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63(18): 5821-8. (Pubitemid 37187480)
27. Singh SK, Clarke ID, Hide T, et al. Cancer stem cells in nervous system tumors. Oncogene 2004; 23(43): 7267-73. (Pubitemid 39382160)
28. Bosch J, López-Picazo JM, García-Foncillas J, et al. Células madre y cáncer: dilucidando el origen de la célula madre tumoral. Rev Med Univ Navarra 2007; 51(2): 40-2.
29. Polyak K, Hahn WC. Roots and stems: stem cells in cancer. Nat Med 2006; 12(3): 296-300. (Pubitemid 43355075)
30. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 1994; 367(6464): 645-8. (Pubitemid 24067706)
31. Wicha MS. Cancer stem cell heterogeneity in hereditary breast cancer. Breast Cancer Res 2008; 10(2): 105.
32. Al-Hajj M, Wicha MS, Benito-Hernández A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100(7): 3983-8. (Pubitemid 36418143)
33. Charafe-Jauffret E, Ginestier C, Iovino F, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009; 69(4): 1302-13.
34. Clevers H. Stem Cells, asymmetric division and cancer. Nat Genet 2005; 37(10): 1027-8.
35. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumors: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8(10): 755-68.
36. Dalerba P, Clarke MF. Cancer Stem Cells and Tumor Metastasis: First Steps into Uncharted Territory. Cell Stem Cell 2007; 1(3): 241-2.
37. Sneddon JB, Werb Z. Location, location, location: The cancer stem cell niche. Cell Stem Cell 2007; 1(6): 607-11. (Pubitemid 350215340)
38. Clarke MF, Fuller M. Stem Cells and Cancer: Two faces of Eve. Cell 2006; 124(6): 1111-15.
39. Majeti R, Becker MW, Tian Q, et al. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Natl Acad Sci USA 2009; 106(9): 3396-401.
40. Korkaya H, Wicha MS. HER-2, Notch, and Breast Cancer Stem Cells: Targeting an Axis of Evil. Clin Cancer Res 2009; 15(6): 1845-7.
41. Clarke MF, Dick JE, Dirks PB, et al. Cancer Stem Cells-Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells. Cancer Res 2006; 66(19): 9339-44. (Pubitemid 44623625)
42. Meléndez J, Maldonado V. Células troncales cancerosas: ¿Clave para curar el cáncer? Ciencia y Desarrollo 2008; 34(224): 28-31.
43. Klonisch T, Wiechec E, Hombach-Klonisch S, et al. Cancer stem cells markers in common cancers-therapeutic implications. Trends Mol Med 2008; 14(10): 450-60.
44. Rosen JM, Jordan CT. The increasing complexity of the cancer stem cell paradigm. Science 2009; 324(5935): 1670-3.
45. Dave B, Chang J. Treatment Resistance in Stem Cells and Breast Cancer. J Mammary Gland Biol Neoplasia 2009; 14(1): 79-82.
46. Iwasaki H, Suda T. Cancer stem cells and their niche. Cancer Sci 2009; 100(7): 1166-72.